Skip to main content

SB 842 — Missouri

Establishes "Cindi's Law" requiring certain diagnostic tests for uterine cancer

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SB 842 - This act establishes "Cindi's Law", requiring all tests of abnormal cytological or histological endometrial samples from the uterine lining to include a test to detect the presence and pattern of abnormalities in the p53 protein for the purposes of diagnosis and treatment of uterine cancer.
SARAH HASKINS

Official abstract, as published by the legislature.

  • SB 842 is a bill in the Missouri Senate, 2026 session, introduced December 1, 2025.
  • Sponsored by Mike Bernskoetter.
  • Current status: introduced.
  • Most recent action (January 8, 2026): Second Read and Referred S Insurance and Banking Committee.
  • Subjects: Health Care, Health Care Professionals, Medical Procedures and Personnel.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Mike Bernskoetter

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Prefiled
  2. Senate S First Read
  3. Senate Second Read and Referred S Insurance and Banking Committee Latest

Source: Open States. Last checked November 6, 2026. How we keep this accurate ›